Background & Opportunity
The prevalence of cardiovascular disease (CVD) continues to rise across Europe, driven by demographic ageing, lifestyle risk factors, and constrained healthcare resources. Real-world access to advanced diagnostics such as ambulatory ECG monitoring and AI-powered rhythm analysis remains limited — particularly in outpatient settings, smaller clinics and underserved regions.
Our Aim & Strategy
We set out to build a growth model that would allow rapid deployment of our ECG-AI solutions across Europe, supporting clinics of different sizes, geographies and resource levels. Key milestones included:
- Developing a robust AI engine that could reliably analyse long-term ECG data.
- Packaging our pipeline into a user-friendly cloud-native platform.
- Designing market-entry frameworks (pricing, local partnerships, training, regulatory compliance) tailored for European clinic environments.
Current State & Results
Within less than two years we moved from 100 clinic installations to around 500 clinics across Europe. This scale implies a major shift in how ECG rhythm monitoring and analysis are delivered — enabling broader access, faster turnaround, and more efficient use of cardiology resources.